In bovine adrenal microsomes, Ins(1,4,5)P3 binds to a specific high-affinity receptor site (Kd = 1I1 nM) with low affinity for two other InsP3 isomers, Ins(1,3,4)P3 and Ins(2,4,5)PJ. In the same subcellular fractions Ins(1,4,5)P3 was also the most potent stimulus of Ca2+ release of all the inositol phosphates tested. Of the many inositol phosphates recently identified in angiotensin-II-stimulated adrenal glomerulosa and other cells, Ins(1,3,4,5)P4 has been implicated as an additional second messenger that may act in conjunction with Ins(1,4,5)P1 to elicit Ca2l mobilization. In the present study, an independent action of Ins(1,3,4,5)P4 was observed in bovine adrenal microsomes. Heparin, a sulphated polysaccharide which binds to Ins(1,4,5)P3 receptors in several tissues, inhibited both the binding of radiolabelled Ins(1,4,5)P3 and its Ca2+-releasing activity in adrenal microsomes. In contrast, heparin did not inhibit the mobilization of Ca2' by Ins(1,3,4,5)P4, even at doses that abolished the Ins(1,4,5)P3 response. Such differential inhibition of the Ins(1,4,5)P3-and Ins(1,3,4,5)P4-induced Ca2+ responses by heparin indicates that Ins(1,3,4,5)P4 stimulates the release of Ca2+ from a discrete intracellular store, and exerts this action via a specific receptor site that is distinct from the Ins(1,4,5)P3 receptor.
INTRODUCTION
The hydrolysis of inositol phospholipids during receptor activation by Ca2+-mobilizing agonists results in the production of Ins(1,4,5)P3 and diacylglycerol (Berridge & Irvine, 1984) . In angiotensin-stimulated bovine adrenal-glomerulosa cells, rapid formation of Ins(l,4,5)P3 is accompanied by mobilization of Ca2+ from vesicular intracellular stores that co-purify with the plasmamembrane fraction during centrifugal fractionation of adrenal homogenates (Baukal et al., 1985; Guillemette et al., 1987a; Rossier et al., 1989) . Several other inositol phosphates are formed in angiotensin-stimulated glomerulosa cells, including Ins(1, 3, 4) P3 and Ins(1,3,4,5)P4 (Guillemette et al., 1987b) , but the physiological role of these compounds is unclear. Specific binding sites for Ins (1, 3, 4, 5) P4 have been identified in several cell types (Theibert et al., 1987; Bradford & Irvine, 1987; Enyedi & Williams, 1988; Enyedi et al., 1989) , suggesting that there is a receptor through which Ins(1,3,4,5)P4 may act on intracellular processes.
Recent studies have suggested that Ins(1,3,4,5)P4 may play a role in the mobilization of Ca2+ from intracellular stores, possibly by acting in conjunction with Ins(1,4,5)P3 (see review by Irvine et al., 1988) . However, to date there have been no reports of a direct and independent action of Ins(1,3,4,5)P4 on Ca2+ mobilization in either whole-or broken-cell preparations. In fact, one study has suggested that Ins(1,3,4,5)P4 may even induce Ca2+ sequestration under certain conditions (Hill et al., 1988) .
Heparin sulphate has been shown to act as a potent inhibitor of Ins(1,4,5)P3-induced Ca2+ release in a variety of cell types (Hill et al., 1987; Nilsson et al., 1988; Ghosh et al., 1988) by preventing the binding of Ins(1,4,5)P3 to its receptor Guillemette et al., 1989) . The results of the present study confirm that heparin inhibits Ins(1,4,5)P3 binding in a dose-dependent manner and also selectively inhibits the Ins(1,4,5)P3-induced Ca2+ response. We also report the finding of an Ins(1,3,4,5)P4-induced Ca2+ mobilization in bovine adrenal microsomes that was not inhibited by heparin. In addition, evidence is presented to show that the Ca2+-mobilizing action of Ins(1,3,4,5)P4 is not the result of its rapid metabolism to Ins(1,4,5)P3.
These results provide evidence that Ins (1, 3, 4, 5) Preparation of particulate cell fraction for binding studies A particulate subcellular fraction containing microsomal membranes was prepared from bovine adrenal cortices, which were homogenized first with a Polytron (setting 10, 15 s) and then with five strokes of a Dounce homogenizer (tight pestle) in 20 mM-NaHCO3. The homogenate was then filtered through nylon mesh and centrifuged at 500 g for 15 min. The supernatant was centrifuged at 35 000 g for 20 min, and the pellet was washed and centrifuged again, resuspended in 20 mM-Tris/HCI, pH 7.4, at a concentration of 15-20 mg of protein/ml and stored at -70°C until utilized.
Hepes, 20 mM-NaCl, 100 mM-KCl, 1 mM-EDTA and 1 mg of BSA/ml. Incubations were performed in a final volume of 200 1ld with [32P]Ins(I,4,5)P3 (25000 d.p.m. 10 fmol % 0.05 nM) and the appropriate concentrations of unlabelled inositol phosphates. Non-specific binding was determined by the addition of 10 fIMIns(1,4,5)P3. After 20 min at 0°C, the incubation was terminated by dilution of samples with 3 ml of ice-cold phosphate-buffered saline (138 mM-NaCI/2.8 mM-KCl/0.8 mM-Na2HPO4/1.45 mM-KH2PO4), pH 7.0, and rapid filtration through GF/C filters (Whatman), followed by 3 x 3 ml washes with the same solution. The bound radioactivity on the filters was measured by ,-spectrometry in a liquid-scintillation counter.
Ca2+-release studies Bovine adrenocortical tissue was dissected from fresh adrenal glands and homogenized in Buffer A (20 mM-Hepes/ KOH, pH 7.2, 110 mM-KCI, 10 mM-NaCl, 2 mM-MgCI2, 5 mm-KH2PO4, 2 mM-EGTA and 1 mM-dithiothreitol) by using a Polytron (setting 10, 15 s) and then a Dounce homogenizer (five strokes, tight pestle). The homogenate was filtered through nylon mesh before centrifugation at 500 g for 15 min. The supernatant was then centrifuged at 35000 g for 20 min, and the subsequent pellet was resuspended in Buffer B (Buffer A, without EGTA) and re-centrifuged. The pellet was washed once again, and the final pellet was resuspended in an intracellular-type buffer composed of 110 mM-KCl, 10 mM-NaCI, 2 mM-MgCl2, 5 mM-KH2PO4 and 20 mM-Hepes/KOH, pH 7.2. The volume was adjusted to give a final concentration of 30 mg of protein/ml.
A 400 1l portion of the particulate suspension (5-6 mg of protein) was added to a quartz cuvette containing the intracellular medium to give a final volume of 2 ml. An ATP-regenerating system composed of 20 units of creatine kinase/ml and 20 mmphosphocreatine was added to the medium and 2.5 ,ug of oligomycin/ml to inhibit mitochondrial ATPase activity.
The changes in free Ca2+ concentration of the incubation medium containing the adrenal particles were monitored by using the fluorescent calcium indicator Fura-2 free acid (1 #M) in a Perkin-Elmer LS-5 fluorescence spectrophotometer. The data were collected by using an excitation wavelength of 340 nm (slit 5 nm) and emission wavelength of 500 nm (slit 10 nm).
In order to detect a Ca2+ response from the test compounds, the microsomes were first re-loaded with Ca2+ by addition of ATP (1 mM The inositol phosphates and heparin to be tested for Ca2+-releasing activity were added in small volumes to the cuvette, and each experiment was calibrated by the addition of a known amount of Ca2+. The free Ca2+ concentration of the medium was determined from the F.ax and Fin. (Grynkiewicz et al., 1985) . The (100000 c.p.m.) in the presence of 2 /tM unlabelled Ins(1,3,4,5)P4; at various times 100 ,1 samples were removed from the cuvette, and the incubation was stopped by addition to 100 ,ul of ice-cold 100% (w/v) HC104.
The samples were centrifuged (2000 g, 20 min) , and the supernatant containing the solubilized inositol phosphates was extracted with trifluoroethane/trioctylamine (1:1, v/v) (Downes et al., 1986 ). Samples were neutralized and then analysed by h.p.l.c. on an Absorbosphere SAX column (5 ,um) (Alltech Associates, Deerfield, IL, U.S.A.) and eluted with a linear gradient of ammonium phosphate as previously described (Balla et al., 1986) 
RESULTS
Bovine adrenal membranes contain high-affinity low-capacity binding sites for Ins(1,4,5)P3.
[32P]Ins(1,4,5)PJ binding to particulate receptor sites was inhibited by increasing amounts of unlabelled Ins(1,4,5)PJ3 and was completely abolished by addition of 1 #M-Ins(l,4,5)P3 (Fig. la) . Scatchard analysis (Fig. 1, inset) of the displacement data indicates that Ins(1,4,5)P3 binds to a single, specific, high-affinity receptor site in bovine adrenal microsomes, with a Kd of 11.2 + 2.9 nm and a binding capacity of 388 + 60.2 fmol/mg of protein (means + S.E.M.; n = 14).
The competition by other inositol phosphates for binding of Ins(1,4,5)P3 to its receptor site is shown in Fig. 1 However, previous studies in bovine adrenal-glomerulosa cells indicate that under physiological conditions Ins(1,4,5)P3 levels are at least 2-5 times those of Ins(1,3,4,5)P4 (Balla et al., 1988) . (1) followed within 10 s by (2). Panel (d): (2) followed within 10 s by (1). Panel (e): (3) followed within 15 s by (2). Panel (f): (2) followed after 2.5 min by (3). The Ins(l,3,4,5)P4 response typically exhibited different kinetics from those of the InsP3-induced Ca2" response, showing a secondary rise or plateau after the initial spike in the free Ca2" level.
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Considering that Ins(1,3,4,5)P4 has about one-seventh the affinity of Ins(1,4,5)P3 for its receptor, it is unlikely that Ins(1,3,4,5)P4 exerts its physiological activity through the Ins(1,4,5)P3 receptor.
The Ca2+ signals generated by the addition of Ins(1,4,5)P3 and Ins(1,3,4,5)P4 to adrenal microsomes exhibited different response kinetics. Typically, the response to Ins(1,4,5)P3 was a prompt rise to a peak Ca2+ level followed by a relatively rapid exponential decay back to baseline levels. The Ca2+ response to Ins(1,3,4,5)P4, particularly at higher doses, usually exhibited a peak, followed by a prolonged phase or plateau, frequently with a secondary rise after the initial peak and a slow decay toward baseline levels, which were not usually attained during the 10 min observation period (Fig. 2a) (Fig. 2b) .
The independent effect of a maximal dose of Ins(1,3,4,5)P4 was superimposable on the Ins(1,4,5)P3-induced Ca2+ release. When Ins(1,3,4,5)P4 was added shortly after a maximal dose of Ins-(1,4,5)P3 (10 s), there was an additional small increase in the amount of Ca2' released (Fig. 2c) ; however, the rapid decay in the Ca2+ response seen with Ins(1,4,5)P3 alone was slowed by the addition of Ins(1,3,4,5)P4, and pre-stimulated baseline levels were not attained. The additive effect of the Ins(1,3,4,5)P4-induced Ca2+ release was more evident when the order of addition was reversed. When Ins(1,4,5)P3 was added after Ins(1,3,4,5)P4, a marked additional increase in Ca2' release was observed and the characteristic Ins(1,4,5)P3-stimulated Ca2+-response kinetics were superimposed on top of the Ins(1,3,4,5)P4-induced Ca2+ response (Fig. 2d) . This independent effect of Ins(1,3,4,5)P4 on Ca2+ release could also be clearly seen when Ins(2,4,5)P3, a nonmetabolized analogue of Ins(1,4,5)P3, was utilized. Ins(2,4,5)P3 (1,3,4,5)P4 was added after Ins(2,4,5)P3 there was a discernible increase in Ca2+ release (Fig. 2e) . This additivity was more apparent when Ins(1,3,4,5)P4 was added before Ins(2,4,5)P3 (Fig.  2f) Fig. 3 ). At lower doses Ins(2,4,5)P3 appeared to be a partial agonist: comparing 2/tM doses, Ins(2,4,5)P3 was less than oneseventh as potent as Ins(1,4,5)P3 and one-third as potent as Ins-(1,3,4,5)P4, in Ca2+-releasing activity. However, at very high doses () 20 4M) the Ca2+ response induced by Ins(2,4,5)P3 surpassed the Ca2+-releasing potency of Ins(1,3,4,5)P4 (Fig. 3) .
Several reports have shown that heparin is a potent inhibitor of both Ins(1,4,5)P3 binding and Ins(1,4,5)P3-stimulated Ca2+ release Ghosh et al., 1988; Nilsson et al., 1988; Guillemette et al., 1989) . Addition of heparin (200 ,ug/ml) to the microsomal preparation, after establishing the Ca2+ heparin tested (Fig. 5) indicate that a dose of 50 ,g/ml was sufficient to inhibit binding of [32P]Ins(1,4,5)P3 by more than 50%; 500 jug of heparin/ml completely inhibited binding of Ins(1,4,5)P3. The inhibition of Ins(1,4,5)P3 binding by heparin has been reported to have an IC50 of 5-10 ,ug/ml, similar to the IC50 values reported for heparin inhibition of Ins(1,4,5)P,-stimulated Ca2l release (Hill et al., 1987; Worley et al., 1987; Ghosh et al., 1988; Nilsson et al., 1988; Guillemette et al., 1989 ).
The Ca2+-mobilizing effect of Ins(1,3,4,5)P4 in adrenal microsomes appears to be due to the intrinsic activity of the tetrakisphosphate itself. However, a recent report has shown that an apparent Ca2+-releasing action of Ins(1,3,4,5)P4 was due to its rapid conversion into Ins(1,4,5)P3 (Cullen et al., 1989) and was almost completely dephosphorylated after 5 min. A concomitant slow rise in the formation of Ins(1,4)P2 was attributable to the dephosphorylation of Ins(1,3,4)P3. There was also a small degree of dephosphorylation of Ins(1,3,4,5)P4 to Ins(1,4,5)P3, as determined by h.p.l.c. analysis, with a gradual increase from 10 s to 5 min. The extent of this conversion, which was at most 5 % of the added radioactivity, corresponds to approx. 100 nM-Ins(l,4,5)P3 (Fig. 6, inset) . The Ca2+ response of our membrane preparation to this concentration of Ins(1,4,5)P3 was barely detectable above baseline. The finding that Ins(1,4,5)P3 was a very minor product of Ins(1,3,4,5)P4 metabolism is in agreement with previous studies in permeabilized adrenal cells, which suggest that Ins(1,3,4,5)P4 is predominantly dephosphorylated to Ins(1,3,4)P3 (Balla et al., 1988) . suggested that the Ins(1,3,4,5)P4-stimulated Ca2+ mobilization was due to the action of Ins(1,3,4,5)P4 at a site that was independent of the Ins(1,4,5)P3 receptor. Heparin appears to be a selective inhibitor at the adrenal InsP1-receptor site in terms of binding and Ca2+ responses. In the bovine adrenal microsomal preparation (J. A. Ely, unpublished work) and in studies on a rat liver cell line (Hill et al., 1987) (Bradford & Irvine, 1987; Theibert et al., 1987; Enyedi & Williams, 1988) (1,3,4,5)P4 via its dephosphorylation by a specific 3-phosphatase, in addition to its dephosphorylation by a 5-phosphatase to form Ins(1,3,4)P3 (Doughney et al., 1988; Hoer et al., 1988; Cullen et al., 1989) . It (Polokoff et al., 1988; Strupish et al., 1988 ).
In conclusion, the individual effects of Ins(1,4,5)PJ and Ins-(1,3,4,5)P4 on Ca2+ release, the different kinetics of the Ca2+ response induced by these two compounds, and the differential inhibitory effect of heparin on the two responses, suggest that Ins(1,3,4,5)P4 acts on a specific receptor to exert an independent effect on the release or transfer of intracellular Ca21 in adrenocortical cells.
